Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Inv. presentation
Quarterly results

Sierra Oncology, Inc. (SRRA) Create: Alert

All | News | Filings
Date FiledTypeDescription
02/14/2023 SC 13G/A Rock Springs Capital Management LP reports a 0% stake in Sierra Oncology, Inc.
02/10/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
07/11/2022 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
07/11/2022 15-12G Form 15-12G - Securities registration termination [Section 12(g)]:
07/08/2022 EFFECT Form EFFECT - Notice of Effectiveness:
07/08/2022 EFFECT Form EFFECT - Notice of Effectiveness:
07/05/2022 SC 13G/A Vivo Capital IX, LLC reports a 0% stake in Sierra Oncology, Inc.
07/01/2022 4 Vivo Opportunity, LLC (10% Owner) has filed a Form 4 on Sierra Oncology, Inc.
Txns: Disposed/sold 161,712 shares @ $55, valued at $8.9M
Disposed/sold 2,735,853 shares @ $55, valued at $150.5M
Disposed/sold 431,947 shares @ $55, valued at $23.8M
Disposed/sold 324,740 options to buy @ $13.2, valued at $4.3M
Disposed/sold 1,455,384 options to buy @ $13.2, valued at $19.2M
Disposed/sold 75,749 options to buy @ $13.2, valued at $999.9k
07/01/2022 4 ORBIMED ADVISORS LLC (10% Owner) has filed a Form 4 on Sierra Oncology, Inc.
Txns: Disposed/sold 1,511,362 shares @ $55, valued at $83.1M
Disposed/sold 226,704 shares @ $55, valued at $12.5M
Disposed/sold 1,136,250 options to buy @ $13.2, valued at $15M
Disposed/sold 170,437 options to buy @ $13.2, valued at $2.2M
07/01/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/01/2022 4 Aggarwal Gaurav (Director) has filed a Form 4 on Sierra Oncology, Inc.
Txns: Disposed/sold 2,735,853 shares @ $55, valued at $150.5M
Disposed/sold 1,500 options to buy @ $13.87, valued at $20.8k
Disposed/sold 6,874 options to buy @ $13.98, valued at $96.1k
Disposed/sold 6,000 options to buy @ $18.11, valued at $108.7k
Disposed/sold 1,455,384 options to buy @ $13.2, valued at $19.2M
07/01/2022 4 Sinclair Andrew (Director) has filed a Form 4 on Sierra Oncology, Inc.
Txns: Disposed/sold 1,314,127 shares @ $55, valued at $72.3M
Disposed/sold 1,500 options to buy @ $13.868, valued at $20.8k
Disposed/sold 6,874 options to buy @ $13.98, valued at $96.1k
Disposed/sold 6,000 options to buy @ $18.11, valued at $108.7k
Disposed/sold 871,125 options to buy @ $13.2, valued at $11.5M
07/01/2022 4 Klencke Barbara (Chief Medical Officer) has filed a Form 4 on Sierra Oncology, Inc.
Txns: Disposed/sold 10,000 shares @ $55, valued at $550k
Disposed/sold 5,000 shares @ $55, valued at $275k
Disposed/sold 11,744 options to buy @ $268.2, valued at $3.1M
Disposed/sold 2,061 options to buy @ $263.2, valued at $542.5k
Disposed/sold 11,399 options to buy @ $72.8, valued at $829.8k
Disposed/sold 1,749 options to buy @ $58, valued at $101.4k
Disposed/sold 4,508 options to buy @ $94.4, valued at $425.6k
Disposed/sold 4,999 options to buy @ $78.4, valued at $391.9k
Disposed/sold 167,091 options to buy @ $13.31, valued at $2.2M
Disposed/sold 49,000 options to buy @ $12.15, valued at $595.4k
Disposed/sold 30,000 options to buy @ $16.73, valued at $501.9k
07/01/2022 4 Jagpal Sukhi (CFO) has filed a Form 4 on Sierra Oncology, Inc.
Txns: Disposed/sold 3,859 options to buy @ $122.2, valued at $471.6k
Disposed/sold 1,218 options to buy @ $263.2, valued at $320.6k
Disposed/sold 4,200 options to buy @ $72.8, valued at $305.8k
Disposed/sold 1,750 options to buy @ $58, valued at $101.5k
Disposed/sold 4,509 options to buy @ $94.4, valued at $425.6k
Disposed/sold 5,000 options to buy @ $78.4, valued at $392k
Disposed/sold 94,113 options to buy @ $13.31, valued at $1.3M
Disposed/sold 49,000 options to buy @ $12.15, valued at $595.4k
Disposed/sold 5,887 options to buy @ $12.15, valued at $71.5k
Disposed/sold 30,000 options to buy @ $16.73, valued at $501.9k
Disposed/sold 50,000 options to buy @ $31.54, valued at $1.6M
07/01/2022 4 Pelzer Robert (Director) has filed a Form 4 on Sierra Oncology, Inc.
Txns: Disposed/sold 671 options to buy @ $268.2, valued at $180k
Disposed/sold 970 options to buy @ $82.4, valued at $79.9k
Disposed/sold 625 options to buy @ $45.2, valued at $28.3k
Disposed/sold 625 options to buy @ $130.8, valued at $81.8k
Disposed/sold 750 options to buy @ $26.4, valued at $19.8k
Disposed/sold 16,686 options to buy @ $13.98, valued at $233.3k
Disposed/sold 6,000 options to buy @ $18.11, valued at $108.7k
07/01/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/01/2022 4 Allen Andrew R (10% Owner) has filed a Form 4 on Sierra Oncology, Inc.
Txns: Disposed/sold 1,650 shares @ $55, valued at $90.8k
Disposed/sold 750 options to buy @ $26.4, valued at $19.8k
Disposed/sold 1,250 options to buy @ $76.8, valued at $96k
Disposed/sold 625 options to buy @ $130.8, valued at $81.8k
Disposed/sold 12,030 options to buy @ $13.98, valued at $168.2k
Disposed/sold 6,000 options to buy @ $18.11, valued at $108.7k
07/01/2022 4 Collard Craig A (Director) has filed a Form 4 on Sierra Oncology, Inc.
Txns: Disposed/sold 13,500 shares @ $55, valued at $742.5k
Disposed/sold 10,000 options to buy @ $13.88, valued at $138.8k
Disposed/sold 6,000 options to buy @ $18.11, valued at $108.7k
07/01/2022 4 DILLY STEPHEN GEORGE (CEO and President) has filed a Form 4 on Sierra Oncology, Inc.
Txns: Disposed/sold 5,000 shares @ $55, valued at $275k
Disposed/sold 520,000 options to buy @ $14.03, valued at $7.3M
Disposed/sold 260,000 options to buy @ $12.15, valued at $3.2M
Disposed/sold 92,000 options to buy @ $16.73, valued at $1.5M
Disposed/sold 165,000 options to buy @ $31.54, valued at $5.2M
07/01/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/01/2022 4 Turner William D. (Chief Reg & Tech Ops Officer) has filed a Form 4 on Sierra Oncology, Inc.
Txns: Disposed/sold 75,000 options to buy @ $12.05, valued at $903.8k
Disposed/sold 49,000 options to buy @ $12.15, valued at $595.4k
Disposed/sold 12,300 options to buy @ $16.73, valued at $205.8k
Disposed/sold 35,000 options to buy @ $31.54, valued at $1.1M
07/01/2022 4 Norrett Kevin (Chief Business Officer) has filed a Form 4 on Sierra Oncology, Inc.
Txns: Disposed/sold 100,000 options to buy @ $12.05, valued at $1.2M
Disposed/sold 49,000 options to buy @ $12.15, valued at $595.4k
Disposed/sold 11,700 options to buy @ $16.73, valued at $195.7k
Disposed/sold 35,000 options to buy @ $31.54, valued at $1.1M
07/01/2022 4 Oliger Christy J. (Director) has filed a Form 4 on Sierra Oncology, Inc.
Txns: Disposed/sold 18,000 options to buy @ $17.7575, valued at $319.6k
07/01/2022 4 Erbez Georgia (Director) has filed a Form 4 on Sierra Oncology, Inc.
Txns: Disposed/sold 18,000 options to buy @ $17.7575, valued at $319.6k
07/01/2022 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
07/01/2022 POS AM Form POS AM - Post-Effective amendments for registration statement:
07/01/2022 POS AM Form POS AM - Post-Effective amendments for registration statement:
07/01/2022 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
07/01/2022 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
07/01/2022 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
07/01/2022 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
07/01/2022 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
07/01/2022 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
07/01/2022 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy